| STAR Stock | | | 665.90 24.70 3.85% |
Founder
Arun BCom is Founder Chairperson of Strides Pharma Science
| Age | 64 |
| Address | Strides House, Bengaluru, India, 560076 |
| Phone | 91 80 6784 0000 |
| Web | https://www.strides.com |
Strides Pharma Management Efficiency
The company has return on total asset
(ROA) of
0.0678 % which means that it generated a profit of $0.0678 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0819 %, meaning that it generated $0.0819 on every $100 dollars invested by stockholders. Strides Pharma's management efficiency ratios could be used to measure how well Strides Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
Other Current Assets is likely to gain to about 6.1
B in 2025, whereas
Total Assets are likely to drop slightly above 50.9
B in 2025.
Similar Executives
Strides Pharma Science (STAR) is traded on National Stock Exchange of India in India and employs 3,065 people. Strides Pharma is listed under Pharmaceuticals category by Fama And French industry classification.
Management Performance
Strides Pharma Science Leadership Team
Elected by the shareholders, the Strides Pharma's board of directors comprises two types of representatives: Strides Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Strides. The board's role is to monitor Strides Pharma's management team and ensure that shareholders' interests are well served. Strides Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Strides Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Manjula Ramamurthy, Compliance Secretary | |
| Arun BCom, Founder Chairperson | |
| Badree Komandur, Executive CFO | |
| Aditya Kumar, Executive Director | |
| Christoph Funke, Chief Officer | |
| P Ramaraju, Chief Officer | |
| Lakshmi Narayanan, Chief Officer | |
| Anjani Kumar, Chief Officer | |
| Umesh Kale, Chief Officer | |
| Hariharan Subramanian, Group Finance | |
| Sormistha Ghosh, Group Officer | |
| Jitesh Devendra, President Markets | |
| Leon Moore, Chief Australia | |
| Kevin Cook, Senior Inc | |
| Vinod Nair, Senior Business | |
| Amol Mehta, Senior Markets | |
| Surabhi Loshali, Group Officer | |
| Subodh Marwah, Group CHC | |
| R Ramesh, Senior Treasury | |
| Vikesh Kumar, Group Officer | |
| Venkat Iyer, Chief Specialities | |
| C Sundar, Executive Operations | |
| Sridhar Rao, President Assurance | |
Strides Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Strides Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Strides Stock Analysis
When running Strides Pharma's price analysis, check to
measure Strides Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Strides Pharma is operating at the current time. Most of Strides Pharma's value examination focuses on studying past and present price action to
predict the probability of Strides Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Strides Pharma's price. Additionally, you may evaluate how the addition of Strides Pharma to your portfolios can decrease your overall portfolio volatility.